688363 华熙生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.6392.5348.72815.74514.597
总资产报酬率 ROA (%)2.9472.0356.91011.99711.835
投入资产回报率 ROIC (%)3.4562.4118.25914.67813.979

边际利润分析
销售毛利率 (%)70.68574.07173.32076.99078.066
营业利润率 (%)9.2214.02111.65917.86918.302
息税前利润/营业总收入 (%)8.8153.84411.04217.10117.982
净利润/营业总收入 (%)7.9763.1369.59115.11815.675

收益指标分析
经营活动净收益/利润总额(%)107.334155.07190.87591.27687.827
价值变动净收益/利润总额(%)-2.796-5.2120.3981.0363.150
营业外收支净额/利润总额(%)-0.057-1.193-0.950-0.018-1.725

偿债能力分析
流动比率 (X)2.4992.0442.5582.4472.845
速动比率 (X)1.4191.1131.6291.7412.338
资产负债率 (%)16.28620.98917.55123.02324.005
带息债务/全部投入资本 (%)0.3840.2340.1733.4782.381
股东权益/带息债务 (%)24,956.41340,161.14255,551.4262,675.7143,924.090
股东权益/负债合计 (%)511.836374.818467.119331.894316.387
利息保障倍数 (X)-21.999-29.680-21.787-22.350-1,798.523

营运能力分析
应收账款周转天数 (天)46.64733.18826.53823.92027.976
存货周转天数 (天)345.188307.927254.954230.122196.693